Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 1
2011 2
2012 1
2013 2
2014 4
2015 2
2016 5
2017 1
2019 3
2020 3
2021 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Rufomycins or Ilamycins: Naming Clarifications and Definitive Structural Assignments.
Zhou B, Achanta PS, Shetye G, Chen SN, Lee H, Jin YY, Cheng J, Lee MJ, Suh JW, Cho S, Franzblau SG, Pauli GF, McAlpine JB. Zhou B, et al. Among authors: jin yy. J Nat Prod. 2021 Oct 22;84(10):2644-2663. doi: 10.1021/acs.jnatprod.1c00198. Epub 2021 Oct 10. J Nat Prod. 2021. PMID: 34628863 Free PMC article.
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
Choules MP, Wolf NM, Lee H, Anderson JR, Grzelak EM, Wang Y, Ma R, Gao W, McAlpine JB, Jin YY, Cheng J, Lee H, Suh JW, Duc NM, Paik S, Choe JH, Jo EK, Chang CL, Lee JS, Jaki BU, Pauli GF, Franzblau SG, Cho S. Choules MP, et al. Among authors: jin yy. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02204-18. doi: 10.1128/AAC.02204-18. Print 2019 Mar. Antimicrob Agents Chemother. 2019. PMID: 30602512 Free PMC article.
Adenovirus type 3 induces platelet activation in vitro.
Jin YY, Yu XN, Qu ZY, Zhang AA, Xing YL, Jiang LX, Shang L, Wang YC. Jin YY, et al. Mol Med Rep. 2014 Jan;9(1):370-4. doi: 10.3892/mmr.2013.1805. Epub 2013 Nov 15. Mol Med Rep. 2014. PMID: 24248552
Discovery and characterization of the tuberculosis drug lead ecumicin.
Gao W, Kim JY, Chen SN, Cho SH, Choi J, Jaki BU, Jin YY, Lankin DC, Lee JE, Lee SY, McAlpine JB, Napolitano JG, Franzblau SG, Suh JW, Pauli GF. Gao W, et al. Among authors: jin yy. Org Lett. 2014 Dec 5;16(23):6044-7. doi: 10.1021/ol5026603. Epub 2014 Nov 19. Org Lett. 2014. PMID: 25409285 Free PMC article.
High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads.
Wolf NM, Lee H, Choules MP, Pauli GF, Phansalkar R, Anderson JR, Gao W, Ren J, Santarsiero BD, Lee H, Cheng J, Jin YY, Ho NA, Duc NM, Suh JW, Abad-Zapatero C, Cho S. Wolf NM, et al. Among authors: jin yy. ACS Infect Dis. 2019 Jun 14;5(6):829-840. doi: 10.1021/acsinfecdis.8b00276. Epub 2019 May 3. ACS Infect Dis. 2019. PMID: 30990022 Free PMC article.
24 results